Hematology Directory Resources

Add URL Hematology

Hematology News

Advanced Cell Technology’s Study Published in Leading Hematology Journal (Centre Daily Times)

Advanced Cell Technology, Inc. (“ACT”) (OTC: ACTC), announced today that their study investigating the feasibility of producing functional, oxygen-carrying red blood cells (RBCs) from mature human embryonic stem cells (hESCs) has been formally published in the print version of the prestigious medical journal Blood – the leading publication in the field of hematology. The study,which was ...

Archemix Announces ARC1779 Data to Be Presented at Upcoming American Society of Hematology (ASH) Annual Meeting, ... (Centre Daily Times)

Archemix Corp., a biotechnology company focused on discovering, developing and commercializing aptamer therapeutics, today announced that data from the company’s Phase 2a clinical trial of ARC1779 will be presented at the 50th Annual Meeting of the American Society of Hematology in San Francisco, Calif., December 6 to 9, 2008.

Ambit Biosciences to Unveil Clinical Data from its AC220 AML Trial at American Society for Hematology Annual Conference (Centre Daily Times)

Ambit Biosciences today announced that data for the company’s lead compound, AC220, will be presented at the 50 th Annual Meeting of the American Society of Hematology (ASH), occurring December 6 through 9, 2008 in San Francisco. Two oral presentations and one poster presentation will highlight clinical and preclinical data for AC220, a compound that potently and selectively inhibits the ...

ZEVALIN® Data to Be Presented at 2008 Annual Meeting of the American Society of Hematology (Centre Daily Times)

Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI) today announced that ZEVALIN ® (ibritumomab tiuxetan) related posters and presentations will be presented at the 50th Annual Meeting of the American Society of Hematology (ASH), December 5-9, 2008 in San Francisco, California.

Advanced Cell Technologys Study Published in Leading Hematology Journal (Business Wire via Yahoo! Finance)

WORCESTER, Mass.----Advanced Cell Technology, Inc. , announced today that their study investigating the feasibility of producing functional, oxygen-carrying red blood cells from mature human embryonic stem cells has been formally published in the print version of the prestigious medical journal Blood – the leading publication in the field of hematology.